« Back to Record
Jones, R. L., Ratain, M. M., O'Dwyer, P. P., Siu, L. L., Jassem, J., Medioni, J., DeJonge, M., Rudin, C., Sawyer, M. M., Khayat, D., Awada, A., de Vos-Geelen, J. J., Evans, T. R. J., Obel, J., Brockstein, B., DeGreve, J., Baurain, J.-F., Maki, R., D'Adamo, D., Dickson, M., Undevia, S., Geary, D., Janisch, L., Bedard, P. L., Abdul Razak, A. R., Kristeleit, R., Vitfell-Rasmussen, J., Walters, I., Kaye, S. S., & Schwartz, G. (2019). Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours. European journal of cancer, 120, 132-139. doi:10.1016/j.ejca.2019.07.024
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/297142



